2017 Q2 Form 10-Q Financial Statement

#000156459017015609 Filed on August 04, 2017

View on sec.gov

Income Statement

Concept 2017 Q2 2016 Q2
Revenue $108.1M $105.0M
YoY Change 2.95% 9.47%
Cost Of Revenue $28.64M $28.50M
YoY Change 0.47% 4.58%
Gross Profit $79.50M $76.54M
YoY Change 3.87% 11.41%
Gross Profit Margin 73.52% 72.87%
Selling, General & Admin $57.30M $53.70M
YoY Change 6.7% 9.82%
% of Gross Profit 72.07% 70.16%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $6.450M $5.680M
YoY Change 13.56% 7.41%
% of Gross Profit 8.11% 7.42%
Operating Expenses $108.0M $99.52M
YoY Change 8.49% 8.34%
Operating Profit $164.0K $5.512M
YoY Change -97.02% 34.97%
Interest Expense $41.00K $41.00K
YoY Change 0.0% -34.92%
% of Operating Profit 25.0% 0.74%
Other Income/Expense, Net
YoY Change
Pretax Income $123.0K $5.471M
YoY Change -97.75% 36.06%
Income Tax $186.0K $2.039M
% Of Pretax Income 151.22% 37.27%
Net Earnings -$138.0K $3.373M
YoY Change -104.09% 37.06%
Net Earnings / Revenue -0.13% 3.21%
Basic Earnings Per Share -$0.01 $0.13
Diluted Earnings Per Share -$0.01 $0.13
COMMON SHARES
Basic Shares Outstanding 25.03M 25.82M
Diluted Shares Outstanding 25.03M 26.46M

Balance Sheet

Concept 2017 Q2 2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $21.20M $29.90M
YoY Change -29.1% -44.73%
Cash & Equivalents $21.18M $29.92M
Short-Term Investments
Other Short-Term Assets $9.200M $5.200M
YoY Change 76.92% -42.22%
Inventory $3.300M $3.000M
Prepaid Expenses
Receivables $5.600M $4.600M
Other Receivables $0.00 $0.00
Total Short-Term Assets $39.30M $42.70M
YoY Change -7.96% -39.88%
LONG-TERM ASSETS
Property, Plant & Equipment $105.3M $95.80M
YoY Change 9.92% 3.44%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $23.30M $22.20M
YoY Change 4.95% 3.26%
Total Long-Term Assets $134.2M $123.6M
YoY Change 8.58% 3.88%
TOTAL ASSETS
Total Short-Term Assets $39.30M $42.70M
Total Long-Term Assets $134.2M $123.6M
Total Assets $173.5M $166.3M
YoY Change 4.33% -12.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.200M $3.900M
YoY Change 7.69% 75.04%
Accrued Expenses $19.70M $18.10M
YoY Change 8.84% -8.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $23.90M $23.30M
YoY Change 2.58% 5.8%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $24.70M $19.90M
YoY Change 24.12% 2746.92%
Total Long-Term Liabilities $24.70M $19.90M
YoY Change 24.12% 2746.92%
TOTAL LIABILITIES
Total Short-Term Liabilities $23.90M $23.30M
Total Long-Term Liabilities $24.70M $19.90M
Total Liabilities $49.40M $43.90M
YoY Change 12.53% 14.02%
SHAREHOLDERS EQUITY
Retained Earnings -$212.5M
YoY Change
Common Stock $413.5M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $77.32M
YoY Change
Treasury Stock Shares $6.167M
Shareholders Equity $124.0M $122.4M
YoY Change
Total Liabilities & Shareholders Equity $173.5M $166.3M
YoY Change 4.31% -12.48%

Cashflow Statement

Concept 2017 Q2 2016 Q2
OPERATING ACTIVITIES
Net Income -$138.0K $3.373M
YoY Change -104.09% 37.06%
Depreciation, Depletion And Amortization $6.450M $5.680M
YoY Change 13.56% 7.41%
Cash From Operating Activities $2.720M $12.26M
YoY Change -77.81% 39.16%
INVESTING ACTIVITIES
Capital Expenditures -$8.400M -$5.560M
YoY Change 51.08% -42.92%
Acquisitions $1.100M
YoY Change
Other Investing Activities $0.00 -$1.110M
YoY Change -100.0%
Cash From Investing Activities -$8.400M -$6.670M
YoY Change 25.94% -31.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -510.0K -9.150M
YoY Change -94.43% 36.77%
NET CHANGE
Cash From Operating Activities 2.720M 12.26M
Cash From Investing Activities -8.400M -6.670M
Cash From Financing Activities -510.0K -9.150M
Net Change In Cash -6.190M -3.560M
YoY Change 73.88% -53.28%
FREE CASH FLOW
Cash From Operating Activities $2.720M $12.26M
Capital Expenditures -$8.400M -$5.560M
Free Cash Flow $11.12M $17.82M
YoY Change -37.6% -3.94%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q2 us-gaap Operating Expenses
OperatingExpenses
107972000
CY2017Q2 us-gaap Net Income Loss
NetIncomeLoss
-138000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1358000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7332000
CY2016Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2039000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
739000
CY2017Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-3341000
CY2016Q2 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1008000
CY2017Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2017Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
186000
CY2017Q2 us-gaap Profit Loss
ProfitLoss
-63000
CY2017Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
75000
CY2017Q2 us-gaap Revenues
Revenues
108136000
us-gaap Net Income Loss
NetIncomeLoss
545000
CY2017Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
28635000
CY2016Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
CY2017Q2 us-gaap Interest Expense
InterestExpense
41000
CY2017Q2 us-gaap Treasury Stock Value
TreasuryStockValue
77317000
CY2017Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-212489000
CY2017Q2 us-gaap Stockholders Equity
StockholdersEquity
124046000
CY2017Q2 us-gaap Minority Interest
MinorityInterest
723000
CY2017Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
124769000
CY2017Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
413539000
CY2017Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
173465000
CY2017Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
123000
us-gaap Operating Income Loss
OperatingIncomeLoss
7401000
pbpb Revenue From Franchise Royalties And Fees
RevenueFromFranchiseRoyaltiesAndFees
1594000
pbpb Revenue From Franchise Royalties And Fees
RevenueFromFranchiseRoyaltiesAndFees
1099000
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
199892000
CY2016Q2 us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
28500000
CY2016Q2 pbpb Revenue From Franchise Royalties And Fees
RevenueFromFranchiseRoyaltiesAndFees
570000
CY2016Q2 us-gaap Revenues
Revenues
105036000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
55298000
CY2016Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
29935000
us-gaap Profit Loss
ProfitLoss
619000
us-gaap Pre Opening Costs
PreOpeningCosts
391000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1025000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.17
us-gaap Operating Income Loss
OperatingIncomeLoss
1427000
CY2016Q2 us-gaap Operating Expenses
OperatingExpenses
99524000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2016Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
59000
CY2016Q2 us-gaap Interest Expense
InterestExpense
41000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
74000
CY2016Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25818571
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25066374
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
26039082
us-gaap Interest Expense
InterestExpense
69000
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-4226000
us-gaap Interest Expense
InterestExpense
69000
CY2016Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
5512000
CY2016Q2 us-gaap Profit Loss
ProfitLoss
3432000
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
99000
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
3373000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20828000
CY2016Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
5471000
us-gaap Net Income Loss
NetIncomeLoss
4461000
us-gaap Depreciation
Depreciation
12645000
CY2016Q2 us-gaap Occupancy Costs
OccupancyCosts
13174000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
62026000
CY2017Q2 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
12252000
us-gaap Cost Of Goods Sold Excluding Depreciation Depletion And Amortization
CostOfGoodsSoldExcludingDepreciationDepletionAndAmortization
54746000
CY2017Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
159000
us-gaap Depreciation
Depreciation
11340000
CY2016Q2 us-gaap Pre Opening Costs
PreOpeningCosts
239000
us-gaap Pre Opening Costs
PreOpeningCosts
619000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26597012
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
3648000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
16000
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
159000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1466000
CY2016Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
123122000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
1115000
pbpb Excess Tax Deficiency Benefit From Stock Based Compensation Operating Activities
ExcessTaxDeficiencyBenefitFromStockBasedCompensationOperatingActivities
89000
pbpb Asset Impairment Store Closure And Disposal Of Property And Equipment
AssetImpairmentStoreClosureAndDisposalOfPropertyAndEquipment
1028000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
16000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
93000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-138000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
113000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-2011000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2197000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
32006000
us-gaap Income Taxes Paid
IncomeTaxesPaid
3253000
us-gaap Interest Paid
InterestPaid
53000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2397000
us-gaap Straight Line Rent
StraightLineRent
-1097000
pbpb Asset Impairment Store Closure And Disposal Of Property And Equipment
AssetImpairmentStoreClosureAndDisposalOfPropertyAndEquipment
4262000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
1376000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
554000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
3813000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
16622000
us-gaap Share Based Compensation
ShareBasedCompensation
1925000
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
130213000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
16622000
CY2016Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26459087
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
113000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
974000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
18000
us-gaap Increase Decrease In Receivables
IncreaseDecreaseInReceivables
1789000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-43000
us-gaap Revenues
Revenues
209835000
us-gaap Revenues
Revenues
200991000
us-gaap Profit Loss
ProfitLoss
4560000
CY2017Q2 us-gaap Labor And Related Expense
LaborAndRelatedExpense
31564000
CY2017Q2 us-gaap Occupancy Costs
OccupancyCosts
14269000
CY2017Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2017Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25125482
CY2017Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
6166996
CY2017Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2017Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
107382000
CY2017Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
164000
us-gaap Operating Expenses
OperatingExpenses
208408000
us-gaap Operating Expenses
OperatingExpenses
193590000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
4996000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1972000
CY2016Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2017Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2017Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25033868
us-gaap Straight Line Rent
StraightLineRent
-579000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1925000
pbpb Contributions From Minority Noncontrolling Interest
ContributionsFromMinorityNoncontrollingInterest
11000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
293000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25981051
pbpb Excess Tax Deficiency Benefit From Stock Based Compensation Operating Activities
ExcessTaxDeficiencyBenefitFromStockBasedCompensationOperatingActivities
-16000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
15326000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-12952000
us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-4616000
CY2017Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25033868
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1511000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3921000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
15140000
us-gaap Share Based Compensation
ShareBasedCompensation
1466000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15326000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1115000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1108000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1972000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4996000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
16000
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
11000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
159000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2085000
CY2016Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
29921000
us-gaap Income Taxes Paid
IncomeTaxesPaid
714000
us-gaap Interest Paid
InterestPaid
57000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1580000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2772000
CY2016Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
1000000
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
1737000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
24153000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12178000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-13286000
us-gaap Fiscal Period
FiscalPeriod
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Fiscal Year</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The Company uses a 52/53-week fiscal year that ends on the last Sunday of the calendar period. Approximately every five or six years a 53rd week is added. Fiscal year 2017 consists of 53 weeks and 2016 consisted of 52 weeks. The fiscal quarters ended June 25, 2017 and June 26, 2016 each consisted of 13 weeks.</p></div>
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, revenues and expenses and the disclosure of contingent assets and liabilities. Significant estimates include amounts for long-lived assets and income taxes. Actual results could differ from those estimates.</p></div>
CY2017Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
31
CY2016Q2 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
1100000
pbpb Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
8
CY2017Q2 pbpb Number Of Joint Ventures
NumberOfJointVentures
5
CY2017Q2 us-gaap Asset Impairment Charges
AssetImpairmentCharges
3300000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4200000
CY2016Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
581971
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
831927
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
504761
CY2016Q2 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
58545
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
82750
us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
53169
CY2017Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
1.512
CY2016Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.373
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.544
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.378
CY2016Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
30000000
CY2015Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
35000000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4105000
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
413584
CY2017Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
22700000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4013000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
263000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
117000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
54000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3124000
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.61
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
11.55
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
9.57
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
14.98
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
10.64
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
9.94
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13455000
CY2017Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
7425000
CY2017Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7140000
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y9M11D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M9D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y6M21D
CY2017Q2 us-gaap Share Based Compensation
ShareBasedCompensation
1100000
CY2016Q2 us-gaap Share Based Compensation
ShareBasedCompensation
800000
CY2017Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
6400000
pbpb Share Based Compensation Arrangement Unrecognized Compensation Expense Expected Term
ShareBasedCompensationArrangementUnrecognizedCompensationExpenseExpectedTerm
2021
CY2017Q1 us-gaap Litigation Settlement Amount Awarded From Other Party
LitigationSettlementAmountAwardedFromOtherParty
1300000

Files In Submission

Name View Source Status
0001564590-17-015609-index-headers.html Edgar Link pending
0001564590-17-015609-index.html Edgar Link pending
0001564590-17-015609.txt Edgar Link pending
0001564590-17-015609-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pbpb-10q_20170625.htm Edgar Link pending
pbpb-20170625.xml Edgar Link completed
pbpb-20170625.xsd Edgar Link pending
pbpb-20170625_cal.xml Edgar Link unprocessable
pbpb-20170625_def.xml Edgar Link unprocessable
pbpb-20170625_lab.xml Edgar Link unprocessable
pbpb-20170625_pre.xml Edgar Link unprocessable
pbpb-ex311_7.htm Edgar Link pending
pbpb-ex321_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending